SWM
BMY.RT

Sugarloaf Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Sugarloaf Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,956
Closed -$12K – 804
2020
Q4 		$12K Hold
16,956
– – ﹤0.01% 468
2020
Q3 		$38K Hold
16,956
– – 0.01% 266
2020
Q2 		$61K Hold
16,956
– – 0.02% 210
2020
Q1 		$64K Hold
16,956
– – 0.03% 193
2019
Q4 		$51K Buy
+16,956
New +$44.1K 0.02% 245

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Sugarloaf Wealth Management's BMY.RT Position: Q1 2021 in Review

Sugarloaf Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 16,956 shares — an estimated $12K sold.

Sugarloaf Wealth Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $64K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Sugarloaf Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Sugarloaf Wealth Management sold 16,956 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $12K.
  • Sugarloaf Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Sugarloaf Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $64K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sugarloaf Wealth Management's 13F filing for Q1 2021, filed 19 Apr 2021.